Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1–98 comparing adjuvant tamoxifen with letrozole - Viale, G; Giobbie-Hurder, A; Regan, M M (J Clin Oncol, 2008)
et al.